Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin and tazarotene help treat acne, while minoxidil and finasteride promote hair growth.

Biological therapy boosts the immune system to effectively fight melanoma.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Finasteride and minoxidil together work best for male hair loss.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.